We are live on ! Find out more
VEA

Virtus ETF Advisers Portfolio holdings

AUM $215M
1-Year Est. Return 53.68%
This Fund
S&P 500
This Quarter Est. Return
+0.14%
1 Year Est. Return
+53.68%
3 Year Est. Return
+121.72%
5 Year Est. Return
+144.54%
10 Year Est. Return
+633.35%
AUM
$204M
AUM Growth
+$15.9M
Cap. Flow
+$17.5M
Cap. Flow %
8.58%
Top 10 Hldgs %
6.14%
Holding
488
New
66
Increased
245
Reduced
135
Closed
40

Top Buys

Rank Stock Value
1
QCOM icon
Qualcomm
QCOM
+$976K
2
NFLX icon
Netflix
NFLX
+$953K
3
CRWD icon
CrowdStrike
CRWD
+$952K
4
RCL icon
Royal Caribbean
RCL
+$905K
5
TJX icon
TJX Companies
TJX
+$890K

Top Sells

Rank Stock Value
1
PXD
Pioneer Natural Resource Co.
PXD
+$1.11M
2
LLY icon
Eli Lilly
LLY
+$937K
3
FCX icon
Freeport-McMoran
FCX
+$933K
4
ALGN icon
Align Technology
ALGN
+$933K
5
MLM icon
Martin Marietta Materials
MLM
+$930K

Sector Composition

Rank Sector Weight
1 Financials 26.66%
2 Healthcare 19.14%
3 Technology 17.16%
4 Energy 7.21%
5 Industrials 6.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CRNX icon
376
Crinetics Pharmaceuticals
CRNX
$8.87B
$86.5K 0.04%
1,931
-548
-22% -$25.3K
KURA icon
377
Kura Oncology
KURA
$901M
$86.4K 0.04%
4,197
-3,057
-42% -$62.8K
AKRO
378
DELISTED
Akero Therapeutics
AKRO
$86.3K 0.04%
3,677
-202
-5% -$4.32K
REPL icon
379
Replimune Group
REPL
$724M
$86.1K 0.04%
9,569
-1,596
-14% -$11.1K
RCKT icon
380
Rocket Pharmaceuticals
RCKT
$355M
$85.3K 0.04%
3,960
+897
+29% +$20.6K
COGT icon
381
Cogent Biosciences
COGT
$6.91B
$85K 0.04%
10,081
-7,386
-42% -$56K
ZYME icon
382
Zymeworks
ZYME
$1.69B
$84.6K 0.04%
9,937
+332
+3% +$2.96K
PGEN icon
383
Precigen
PGEN
$1.93B
$84.1K 0.04%
53,250
-15,514
-23% -$22.5K
BEAM icon
384
Beam Therapeutics
BEAM
$2.58B
$84K 0.04%
3,587
+676
+23% +$16.6K
KROS icon
385
Keros Therapeutics
KROS
$202M
$83.6K 0.04%
1,829
-738
-29% -$39.7K
MLYS icon
386
Mineralys Therapeutics
MLYS
$2.4B
$83.5K 0.04%
7,134
-3,367
-32% -$42.4K
ALEC icon
387
Alector
ALEC
$168M
$83.4K 0.04%
18,362
+7,533
+70% +$38.8K
ORIC icon
388
Oric Pharmaceuticals
ORIC
$1.24B
$83.3K 0.04%
11,787
+2,350
+25% +$21K
ALLO icon
389
Allogene Therapeutics
ALLO
$604M
$83K 0.04%
35,640
+3,673
+11% +$10.8K
APGE icon
390
Apogee Therapeutics
APGE
$10.2B
$82.6K 0.04%
2,099
-1,628
-44% -$79K
BLTE
391
Belite Bio
BLTE
$6.35B
$82.5K 0.04%
1,807
-152
-8% -$6.58K
ITOS
392
DELISTED
iTeos Therapeutics
ITOS
$82.4K 0.04%
5,554
-2,492
-31% -$35.7K
CNTA
393
DELISTED
Centessa Pharmaceuticals
CNTA
$82.3K 0.04%
+9,116
New +$86.5K
MGNX icon
394
MacroGenics
MGNX
$254M
$82.2K 0.04%
19,343
+10,034
+108% +$97.7K
CGON icon
395
CG Oncology
CGON
$6.48B
$82.1K 0.04%
+2,601
New +$90.2K
SLNO
396
DELISTED
Soleno Therapeutics
SLNO
$82K 0.04%
2,011
-316
-14% -$13.4K
IDYA icon
397
IDEAYA Biosciences
IDYA
$3.54B
$81.6K 0.04%
2,325
-210
-8% -$8.32K
PLRX icon
398
Pliant Therapeutics
PLRX
$66.9M
$81.3K 0.04%
7,563
+2,396
+46% +$30.9K
IMTX icon
399
Immatics
IMTX
$1.18B
$81.2K 0.04%
6,990
-1,847
-21% -$20.8K
RCUS icon
400
Arcus Biosciences
RCUS
$3.5B
$81.1K 0.04%
5,325
+414
+8% +$6.68K
14 15
16
17 18

Similar funds

NCM
NEXTBio Capital Management Menlo Park, California $215M AUM
SSA
SSA Swiss Advisors Zurich $216M AUM 17.86% 1-Year Est. Return
LIWM
Long Island Wealth Management Melville, New York $216M AUM 14.59% 1-Year Est. Return
VFG
V2 Financial group Naperville, Illinois $215M AUM 15.18% 1-Year Est. Return
IAM
Impala Asset Management Palm Beach, Florida $215M AUM 86.77% 1-Year Est. Return
1M
1248 Management Kansas City, Missouri $216M AUM 12.29% 1-Year Est. Return
GC
GatePass Capital Independence, Ohio $214M AUM 29.83% 1-Year Est. Return
ALS
Andrew L. Share $214M AUM 14.75% 1-Year Est. Return

Virtus ETF Advisers's Q2 2024 Portfolio in Review

As of Q2 2024, Virtus ETF Advisers held 488 positions worth $204M, up 8.5% from $188M the previous quarter. Its ten largest holdings account for 6.1% of the portfolio.

Virtus ETF Advisers deployed $17.5M of net new capital in Q2 2024, opening 66 new positions and adding to 245 existing holdings. Its largest new stake was Qualcomm: 5,165 shares worth $1.03M.

By sector, the portfolio is most concentrated in Financials at 27% of assets, up from 20% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Extra Space Storage, an estimated $732K trimmed.

  • Virtus ETF Advisers's largest Q2 2024 buy was Qualcomm: 5,165 shares worth $1.03M.
  • Virtus ETF Advisers added most to EOG Resources in Q2 2024, an estimated $789K increase.
  • Virtus ETF Advisers's biggest Q2 2024 reduction was Extra Space Storage, cutting an estimated $732K.
  • Virtus ETF Advisers fully exited Pioneer Natural Resource Co. in Q2 2024, selling an estimated $1.11M.
  • Virtus ETF Advisers's ten largest holdings make up 6.1% of its $204M portfolio in Q2 2024.
  • Virtus ETF Advisers opened 66 new positions and closed 40 in Q2 2024.
  • Virtus ETF Advisers's portfolio value rose 8.5% quarter-over-quarter to $204M.

Based on Virtus ETF Advisers's 13F filing for Q2 2024, filed 14 Aug 2024.